Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balance at beginning of period at Oct. 31, 2020	$ 355,759	$ 373	$ 253,458	$ 213,517	$ (33,024)	$ (78,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,852			7,852
Foreign currency translation adjustment	8,600				8,600
Common dividends ($0.08 per share)	(2,637)			(2,637)
Purchase of treasury stock	(1,927)					(1,927)
Stock-based compensation activity:
Expense related to stock-based compensation	523		523
Stock options exercised	10,030		635			9,395
Restricted stock awards granted			(1,282)			1,282
Performance restricted stock units vested			(565)			565
Other	(492)		(492)
Balance at end of period at Jan. 31, 2021	$ 377,708	373	252,277	218,732	(24,424)	(69,250)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08
Balance at beginning of period at Oct. 31, 2021	$ 419,782	373	254,162	259,718	(21,770)	(72,701)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	11,239			11,239
Foreign currency translation adjustment	(3,159)				(3,159)
Common dividends ($0.08 per share)	(2,587)			(2,587)
Stock-based compensation activity:
Expense related to stock-based compensation	552		552
Stock options exercised	55		5			50
Restricted stock awards granted			(1,534)			1,534
Performance restricted stock units vested			(1,598)			1,598
Other	(1,383)		(1,383)
Balance at end of period at Jan. 31, 2022	$ 424,499	$ 373	$ 250,204	$ 268,370	$ (24,929)	$ (69,519)
Stock-based compensation activity:
Cash dividends per share (in usd per share)	$ 0.08